Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Longo, Nicola"'
Autor:
Luigi Napolitano, Claudio Marino, Angelo Di Giovanni, Assunta Zimarra, Alessandro Giordano, Carlo D’Alterio, Gianluigi Califano, Massimiliano Creta, Giuseppe Celentano, Roberto La Rocca, Claudia Mirone, Gianluca Spena, Alessandro Palmieri, Nicola Longo, Ciro Imbimbo, Marco Capece
Publikováno v:
Journal of Clinical Medicine. 12:2604
Background: Penile injection of foreign materials is an obsolete practice often performed by non-medical personnel in order to enlarge penile size. Methods: A systematic review of the literature from 1956 to 2022 was conducted in accordance with the
Autor:
Benedetta Muzii, Francesco Di Bello, Fabio Carraturo, Tiziana Di Perna, Gianluigi Califano, Simone Morra, Francesco Mangiapia, Cristiano Scandurra, Luigi Giuliani, Giuseppe Celentano, Roberto La Rocca, Massimiliano Creta, Nicola Longo, Nelson Mauro Maldonato, Claudia Collà Ruvolo
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 20; Issue 6; Pages: 4721
The aim of this study is to evaluate YouTube™ content in terms of the quality of information available about prostate cancer (PCa) in relation to incidence, symptomatology, and potential treatments for patients’ mental health. We searched on YouT
Autor:
Francesco Di Bello, Ernesto Di Mauro, Claudia Collà Ruvolo, Massimiliano Creta, Roberto La Rocca, Giuseppe Celentano, Marco Capece, Luigi Napolitano, Agostino Fraia, Gabriele Pezone, Simone Morra, Ciro Imbimbo, Vincenzo Mirone, Nicola Longo, Gianluigi Califano
Publikováno v:
Vaccines; Volume 11; Issue 1; Pages: 92
Background: YouTubeTM is an open-access source for mass information. Several previous studies of YouTubeTM videos showed a high rate of misinformation in the urological field. The aim of the current study was to evaluate the quality of information on
Autor:
Nicola Longo, Giuseppe Celentano, Luigi Napolitano, Roberto La Rocca, Marco Capece, Gianluigi Califano, Claudia Collà Ruvolo, Francesco Mangiapia, Ferdinando Fusco, Simone Morra, Carmine Turco, Francesco Di Bello, Giovanni Maria Fusco, Luigi Cirillo, Crescenzo Cacciapuoti, Lorenzo Spirito, Armando Calogero, Antonello Sica, Caterina Sagnelli, Massimiliano Creta
Publikováno v:
Cancers. 14:2373
Simple Summary Patients with oligometastatic urothelial carcinoma represent a challenging subset of subjects to manage. Herein we summarized evidence about the role of metastasis-directed radiation therapy in this clinical setting. Available prelimin
Autor:
Cristiano Scandurra, Benedetta Muzii, Roberto La Rocca, Francesco Di Bello, Mario Bottone, Gianluigi Califano, Nicola Longo, Nelson Mauro Maldonato, Francesco Mangiapia
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 8; Pages: 4825
Treatments for prostate cancer (PCa), the second most common cancer in men, may affect the body image (BI) of patients, increasing the risk of negative mental health outcomes. However, an enabling social support network may be a protective factor aga
Autor:
Lorenzo Spirito, Ferdinando Fusco, Claudia Collà Ruvolo, Roberto La Rocca, Simone Morra, Vincenzo Mirone, Nicola Longo, Marco Capece, Giuseppe Celentano, Francesco Mangiapia, Gianluigi Califano, Carmine Turco, Luigi Napolitano, Ciro Imbimbo, Massimiliano Creta
Publikováno v:
Diagnostics, Vol 11, Iss 351, p 351 (2021)
Diagnostics
Diagnostics
Bladder cancer (BCa) is an endocrine-related tumour and the activation of androgen signalling pathways may promote bladder tumorigenesis. We summarized the available preclinical and clinical evidence on the implications of the manipulation of androge
Autor:
Luigi Napolitano, Biagio Barone, Francesco Mangiapia, Carmine Turco, Vincenzo Morgera, Claudia Collà Ruvolo, Vincenzo Caputo, Roberto La Rocca, Nicola Longo, Lorenzo Romano, Giuseppe Celentano, Gianluca Spena, Simone Morra, Vincenzo Mirone, Marco Capece, Luigi M. De Luca, Gianluigi Califano, Massimiliano Creta
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 1993, p 1993 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Prader-Willi syndrome (PWS) is a multisystemic complex genetic disorder related to the lack of a functional paternal copy of chromosome 15q11-q13. Several clinical manifestations are reported, such as short stature, cognitive and behavioral disabilit
Autor:
Luca Scafuri, Giuseppe Di Lorenzo, Antonio Verde, Vittorio Riccio, Sabino De Placido, Ciro Imbimbo, Nicola Longo, Valeria Romeo, Felice Crocetto, Pasquale Dolce, Pietro De Placido, Martina Pagliuca, Carlo Buonerba, Rocco Morra, Dario Ribera, Ferdinando Costabile, Simona Iaccarino
Publikováno v:
Cancers, Vol 12, Iss 2, p 408 (2020)
Cancers
Cancers
Immunotherapy based on anti PD-1/PD-L1 inhibitors has proven to be more effective than sunitinib in the first-line setting of advanced renal cell carcinoma (RCC). RCC patients with sarcomatoid histology (sRCC) have a poor prognosis and limited therap
Autor:
Ciro Imbimbo, Francesco Mangiapia, Massimiliano Creta, Marco Capece, Marco De Sio, Nicola Longo, Gianluigi Califano, Ferdinando Fusco, Vincenzo Mirone, Caterina Sagnelli, Giuseppe Celentano, Roberto La Rocca, Lorenzo Spirito, Davide Arcaniolo, Armando Calogero, Antonello Sica, Luigi Vanni, Luigi Napolitano
Publikováno v:
Healthcare, Vol 9, Iss 1123, p 1123 (2021)
Healthcare
Healthcare
Patients suffering from hematological malignancies are at increased risk of Fournier’s gangrene (FG) due to immunosuppression caused by the disease itself or by disease-related treatments. A systematic review of PubMed, ISI Web of Knowledge, and Sc
Autor:
Claudia Collà Ruvolo, Vincenzo Mirone, Massimiliano Creta, Carlo Buonerba, Ferdinando Fusco, Nicola Longo, Gianluigi Califano, Marco Capece, Giuseppe Celentano, Fabio Esposito, Roberto La Rocca, Francesco Mangiapia, Luigi Napolitano
Publikováno v:
Cancers, Vol 12, Iss 3634, p 3634 (2020)
Cancers
Cancers
Simple Summary The management of metastatic renal cell carcinoma (mRCC) represents a clinical challenge. Progression or toxicity may occur during first-line treatments and many patients require a second-line option. Given the expanding options for se